Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate

Haemophilia

Volumn 3, Issue 2, 1997, Pages 90-95

  Ragni, M V ^a,b   Hord, J D ^a   Blatt, J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Catheter; Central venous access; Haemophilia; Line infection; Sepsis

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE;

ADOLESCENT; ADULT; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; GRAM NEGATIVE INFECTION; HEMOPHILIA; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; VASCULAR ACCESS;

EID: 0030980087     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1997.00100.x     Document Type: Article

References (19)

1. Levine PH, Brettler DB. Clinical aspects and therapy for hemophilia A. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen JH, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone, 1991: 1290-1303.
2. Smith PS, Levine PH. The benefits of comprehensive care of hemophilia: a five year study of outcomes. Am J Publ Health 1984; 74: 616-17.
3. Medical Scientific Advisory Council ( MASAC ) recommendations concerning prophylaxis. The National Hemophilia Foundation, Medical Bulletin #193, March, 1994.
4. Schramm W. Experience with prophylaxis in Germany. Sem Hematol 1993; 30 : (Suppl) 12-15.
5. Brackmann HH. Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984; 150: 181-5.
6. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197-210.
7. Buchman AL, Moukarzel A, Goodson B, et al. Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment. JPEN 1994; 18: 297-302.
8. Vora AJ, Lilleyman JS. Vascular access in young hemophiliacs: use of indwelling central venous catheters. Intl J Ped Hem One 1994; 1: 521-7.
9. Ljung K, Petrini P, Landgren AK, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Pediatr 1992; 81: 918-20.
10. Warrier I, Baird-Cox K, Cygan LM, Pfaffmann L, Lusher JM. Experience with central venous catheter (CVC) in children with hemophilia. Thromb Haemost. 1993; 69: 854 (abstr).
11. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119: 1168-74.
12. Riella MC, Scribner BH. Five years' experience with a right atrial catheter for prolonged parenteral nutrition at home. Surgery 1976; 143: 205-8.
13. Martin JK, Beart RW, Mucha P, Hoagland HC. Hickman catheter implantation in the treatment of acute leukemia. Arch Surg 1983; 118: 1224-6.
14. King DR, Komer M, Hoffman J, et al. Broviac catheter sepsis: the natural history of an iatrogenic infection. J Pediatr Surg 1985; 20: 728-33.
15. Pegelow CH, Narvaez M, Toledano SR, Davis J, Oiticica C, Buckner D. Experience with a totally implantable venous device in children. AJDC 1986; 140: 69-71.
16. Colombani PM, Dudgeon DL, Buck JR, et al. Multipurpose central venous access in the immunocompromised pediatric patient. JPEN 1985; 9: 38-41.
17. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995; 75: 1367-75.
18. Reed CR, Sessler CN, Glauser FL, Phelan BA. Central venous catheter infections: concepts and controversies. Intensive Care Med 1995; 21: 177-83.
19. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 1995; 126: 50-4.